Glycoprotein CD44 Expression in Human Breast Cancer: An Immunohistochemical Study Including Correlation with Cathepsin D, Type IV Collagen, Laminin, Fibronectin, EGFR, c-erbB-2 Oncoprotein, p53, Steroid Receptor Status, and Proliferative Indices
- 1 May 1997
- journal article
- Published by Hindawi Limited in The Breast Journal
- Vol. 3 (3) , 112-119
- https://doi.org/10.1111/j.1524-4741.1997.tb00153.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- CD44 and Its Interaction with Extracellular MatrixPublished by Elsevier ,1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- CD44H regulates tumor cell migration on hyaluronate-coated substrate.The Journal of cell biology, 1992
- LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 ReleaseScience, 1990
- Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.The Journal of cell biology, 1989
- A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein familyCell, 1989
- Alternative Splicing In The Control Of Gene ExpressionAnnual Review of Genetics, 1989
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986